Neuvasq Biotechnologies, a ULB spin-off developing pharmaceuticals to restore blood-brain barrier function, announces the appointment…

The laboratory of Benoit Vanhollebeke published a paper in the journal Science on an innovative…

Newton together with public and private investment partners invests in Neuvasq for the development of…